Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omission of Sentinel Lymph Node Biopsy in Triple-negative and HER2-positive Breast Cancer Patients With Radiologic and Pathologic Complete Response in the Breast After Neoadjuvant Systemic Therapy: a Single-arm, Prospective Surgical Trial.

NCT04101851 is registered in ClinicalTrials.gov with Toralf Reimer, MD PhD as lead sponsor.

NCT NCT04101851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04101851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omission of Sentinel Lymph Node Biopsy in Triple-negative and HER2-positive Breast Cancer Patients With Radiologic and Pathologic Complete Response in the Breast After Neoadjuvant Systemic Therapy: a Single-arm, Prospective Surgical Trial.
Lead sponsor
Toralf Reimer, MD PhD
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 13, 2021
Completion date
January 31, 2028
Enrollment
350 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female